Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14213
Abstract: Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively evaluated. We aimed to perform a meta‐analysis of digitalized individual patient outcomes to display and compare absolute… read more here.
Keywords: novel antidiabetic; antidiabetic drugs; numbers needed; drugs cardiovascular ... See more keywords
Purification and identification of a novel antidiabetic peptide from Chinese giant salamander (Andrias davidianus) protein hydrolysate against α-amylase and α-glucosidase
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Food Properties"
DOI: 10.1080/10942912.2017.1354885
Abstract: ABSTRACT This study aimed to purify and identify a novel antidiabetic peptides from Chinese giant salamander (Andrias davidianus) protein hydrolysate and to evaluate its anti-diabetic properties against α-amylase and α-glucosidase. The isolation was done by… read more here.
Keywords: salamander andrias; giant salamander; novel antidiabetic; glucosidase ... See more keywords
Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes.
Sign Up to like & getrecommendations! Published in 2020 at "Current pharmaceutical design"
DOI: 10.2174/1381612826666201109110107
Abstract: BACKGROUND Concerns of elevated cardiovascular risk with some anti-diabetic medications warranted cardiovascular outcome trials to demonstrate cardiovascular safety of newly marketed anti-diabetic drugs. Although these trials were initially designed to evaluate safety, some of these… read more here.
Keywords: safety outcomes; safety; novel antidiabetic; cardiovascular safety ... See more keywords
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24097789
Abstract: Metabolic diseases, particularly diabetes mellitus (DM), are significant global public health concerns. Despite the widespread use of standard-of-care therapies, cardiovascular disease (CVD) remains the leading cause of death among diabetic patients. Early and evidence-based interventions… read more here.
Keywords: inflammation oxidative; stress fibrosis; oxidative stress; novel antidiabetic ... See more keywords
The Anti-Inflammatory Effect of Novel Antidiabetic Agents
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12111829
Abstract: The incidence of type 2 diabetes (T2DM) has been increasing worldwide and remains one of the leading causes of atherosclerotic disease. Several antidiabetic agents have been introduced in trying to regulate glucose control levels with… read more here.
Keywords: effect novel; novel antidiabetic; inflammatory effect; anti inflammatory ... See more keywords